both EMD and IHL are biotech companies, the only way to be successful in biotech is to get FDA approval, to do that a company must go through phase 1,2 and 3.
did EMD contact FDA at all ?
what are the conditions EMD are targeting?
at what stage trials are ?
answers to these questions are the reason why the current IHL market cap is 5 times EMD.
was there any company that got an FDA approval based on real world data ?
IHL strategy is the closest to GW pharma the only success story so far globally.
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-350
-
-
- There are more pages in this discussion • 549 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)